Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6402958 | 1.00 | TLR4 (0.32) | TLR4SCN9A | |
| SCHEMBL18032048 | 1.00 | TLR4 (0.32) | TLR4SCN9A | |
| SCHEMBL6402962 | 1.00 | TLR4 (0.32) | TLR4SCN9A | |
| SCHEMBL20118270 | 0.96 | SCN9A (0.32) | SCN9A | |
| SCHEMBL12032287 | 0.95 | TLR4 (0.34) | TLR4 | |
| SCHEMBL17070280 | 0.95 | — | — | |
| SCHEMBL12032062 | 0.95 | TLR4 (0.34) | TLR4 | |
| SCHEMBL18032114 | 0.93 | — | — | |
| SCHEMBL14226681 | 0.93 | — | — | |
| SCHEMBL18032047 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3810724-B1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2023-11-22 | — | — | EP | disclosed |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | JNC CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-10788715-B2 | Photo-alignment material and photo-alignment method | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2020-09-29 | — | — | US | disclosed |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | JNC CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| US-10723947-B2 | Liquid crystal composition and liquid crystal display device thereof | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-07-28 | — | — | US | disclosed |
| EP-2808375-B1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT PRODUCED USING SAME | DAINIPPON INK & CHEMICALS (JP) | 2020-01-22 | — | — | EP | disclosed |
| US-10457869-B2 | Liquid crystal composition and liquid crystal display device | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2019-10-29 | — | — | US | disclosed |
| US-20190292462-A1 | LIQUID CRYSTAL DISPLAY DEVICE INCLUDING LIQUID CRYSTAL MEDIUM CONTAINING LOW MOLECULAR WEIGHT POLAR COMPOUND FOR HOMOGENEOUSLY ALIGNING LIQUID CRYSTAL MEDIUM | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| US-20190292455-A1 | LOW MOLECULAR WEIGHT POLAR COMPOUND FOR HOMOGENEOUSLY ALIGNING LIQUID CRYSTAL MEDIUM, AND LIQUID CRYSTAL MEDIUM CONTAINING SAME | JNC CORPORATION (JP) | 2019-09-26 | — | — | US | disclosed |
| US-10421907-B2 | Liquid crystal composition and a liquid crystal display including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-24 | — | — | US | disclosed |
| US-6827876-B2 | Using alpha, alpha -difluorocyclohexylidene derivative as starting material to obtain difluoromethyl ether derivative | CHISSO CORPORATION (JP) | 2004-12-07 | — | — | US | disclosed |
| US-20040016906-A1 | Difluoromethyl ether derivative and process for producing the same | JNC CORPORATION (JP) | 2004-01-29 | — | — | US | disclosed |
| US-20040004207-A1 | Difluoromethyl ether derivative and process for producing the same | JNC CORPORATION (JP) | 2004-01-08 | — | — | US | disclosed |
| US-6605747-B2 | Reacting the starting material, an alpha , alpha -difluorocyclohexylidene derivative with a halogen to produce an intermediate, reacting the intermediate with a phenol compound in presence of a base | CHISSO CORPORATION (JP) | 2003-08-12 | — | — | US | disclosed |
| US-20020120168-A1 | Difluoromethyl ether derivative and process for producing the same | JNC PETROCHEMICAL CORPORATION (JP) | 2002-08-29 | — | — | US | disclosed |
| EP-1182186-A2 | Difluoromethyl ether derivative and process for producing the same | CHISSO CORPORATION (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-0844229-B1 | Polyhaloalkyl ether derivatives as well as liquid crystal compositions and liquid crystal display elements containing them | CHISSO CORP (JP) | 2002-02-06 | — | — | EP | disclosed |
| EP-1029842-A2 | Polyhaloalkyl ether derivatives as well as liquid crystal compositions and liquid crystal display elements containing them | CHISSO CORPORATION (JP) | 2000-08-23 | — | — | EP | disclosed |
| US-6007740-A | USED PARTICULARLY TO LOWER THRESHOLD VOLTAGE OF LIQUID CRYSTAL COMPOSITIONS, TO ENLARGE A NEMATIC RANGE, SUCH AS INCREASE IN CLEAR POINT OF LIQUID CRYSTAL COMPOSITIONS AND CONTROL REFRACTIVE ANISOTROPIC VALUE | CHISSO CORPORATION (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0844229-A1 | Polyhaloalkyl ether derivatives as well as liquid crystal compositions and liquid crystal display elements containing them | CHISSO CORPORATION (JP) | 1998-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040004207-A1 | Difluoromethyl ether derivative and process for producing the same | RCC1, PYM1, SCFD1 | TLR4 2836/4885SCN9A 2152/4885 |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | ACP1, MAPK1, PLD1 | TLR4 3809/4885SCN9A 2922/4885 |
| US-20040016906-A1 | Difluoromethyl ether derivative and process for producing the same | RCC1, SCFD1, AFF1 | TLR4 2836/4885SCN9A 2082/4885 |
| US-20020120168-A1 | Difluoromethyl ether derivative and process for producing the same | LEF1, AFF1, RCC1 | TLR4 2989/4885SCN9A 2250/4885 |
| US-10421907-B2 | Liquid crystal composition and a liquid crystal display including the same | CCDC22, LRRK2, ZKSCAN2 | TLR4 4762/4885SCN9A 3138/4885 |
| US-20190292462-A1 | LIQUID CRYSTAL DISPLAY DEVICE INCLUDING LIQUID CRYSTAL MEDIUM CONTAINING LOW MOLECULAR WEIGHT POLAR COMPOUND FOR HOMOGENEOUSLY ALIGNING LIQUID CRYSTAL MEDIUM | ACP1, MAPK1, PLD1 | TLR4 3809/4885SCN9A 2922/4885 |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | ACP1, MFAP1, PHOSPHO1 | TLR4 4693/4885SCN9A 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.